Dr. Yujuan Wang
Yujuan obtained her PhD from Beijing Normal University. She is currently joining the project of prostate cancer m6A profiling to carry out some validation experiments. Next, she is going to carry out a series of CRISPR screens in cancer cell lines, including but not limited to targeting RNA m6A modifications.
Dr. Xin Xu
Xin completed his first postdoc program at the Institute of Microbiology, Chinese Academy of Sciences. After that, he joined He lab in October 2016. Currently, he is working on identifying functional circRNA in prostate cancer, and aim to provide new improved biomarkers and therapy targets that will lead to better diagnosis and treatment of prostate cancer.
Dr. Xinpei Ci
Xinpei obtained her PhD degree in Genetics at Nankai University, China, and received a two-year joint training at Emory University, USA. Her PhD work studied the role of a prostate cancer suppressor gene by using genetically engineered mouse models. She completed her first postdoc training under the supervision of Dr.Yuzhuo Wang at the Vancouver Prostate Centre, UBC, where she utilized patient-derived xenograft models to identify and study driver genes in prostate cancer hormonal therapy resistance. Xinpei joined Dr. Hansen He’s lab in December 2020 and is currently working on epigenetic mechanisms involved in neuroendocrine prostate cancer.
Dr. Tianyi Chen
Tianyi attended Purdue University for college where she majored in Math and Biology. After graduation, she worked as a Research Associate at Indiana University Bloomington for about two years before attending graduate school at Duke University in 2016. For her PhD, she worked on liver regeneration project in which she applied single-cell omics analysis and molecular genetics to understand how mammalian liver orchestrates its effective tissue recovery in response to acute injury. Tianyi joined He lab in September 2022. Outside of the lab, she enjoys reading, hiking, running, and playing with her cat.
Dr. Chengpeng Gui
Chengpeng acquired his MD degree in major of Urological Surgery at Sun Yat-sen University, China. His MD work studied the role of circCHST15 in renal cell carcinoma progression using in vitro & in vivo experiments and mining a genetic predictive model through multi-omics bioinformatics analyses. He seeks to identify and study circular RNAs in prostate cancer precision therapy. He is currently working on circRNA database building, circulation mechanisms and circRNA interaction with TF involved in neuroendocrine prostate cancer.
Dr. Jiaying Li
Jiaying obtained her MD from Sun Yat-sen University, majoring in Urology Surgery. She is currently joining the project of circular RNA in prostate cancer and is going to carry out series experiments.
Peiran received his Honours of Bachelor of Science degree at University of Toronto in Biochemistry. He is now a PhD Candidate in the Department of Medical Biophysics. Peiran is co-supervised by Dr. Ming Tsao. His research is focused on extending the CRISPR screens into SCLC PDX models.
Mona obtained her Honours Bachelor of Science at University of Toronto with a specialist in Laboratory Medicine and Pathobiology and a major in Biochemistry. She is currently a PhD Candidate in the department of Medical Biophysics. Her current project focuses on characterizing circular RNAs implicated in neuroendocrine prostate cancer. Mona is also co-supervised by Dr. Brian Raught to develop a new method for elucidating RNA-protein interactome.
Helen received her undergraduate degree from McMaster University in the BHSc (Hons) program with a specialization in Biochemistry and a minor in Mathematics. She is currently a PhD Candidate in the Department of Medical Biophysics. Her current project focuses on M6A modifications in cancer.
Peter obtained his bachelor’s degree from McGill University with a major in Pharmacology. He is currently a PhD Candidate in the Department of Medical Biophysics. He is interested in characterizing the molecular mechanism and clinical utilization of RNA circularization, and looking at circular RNAs involved in immune regulation and tumour immunity.
Vivian obtained her Honours Bachelor of Science at the University of Waterloo in Molecular Genetics and Bioinformatics. She is currently a PhD Student in the Department of Medical Biophysics, co-supervised by Dr. Bo Wang. She is interested in applying deep learning algorithms to improve RNA therapeutic development and multi-omic integration to decipher cancer etiology.
Magnus obtained his Honours Bachelor of Science from the University of Toronto Scarborough in the Molecular Biology and Biotechnology Co-op program. He spent his Co-op term at the Princess Margaret Cancer Biobank as a Technician. He is currently a MSc student in the Department of Medical Biophysics. His research interests are identifying epigenetic-based therapeutic targets in prostate cancer and the potential of using circulating bacterial DNA methylome as a cancer biomarker.
Lin obtained his master’s degree in Bioinformatics from George Washington University in the U.S. He is currently a PhD Student in the Department of Medical Biophysics. He is interested in methodology development based on high-throughput sequencing data specific for single-cell level. Lin is also co-supervised by Dr. Schwartz to develop new algorithms to integrate multiple modularities to infer cell lineage.
Summer Research Student